Amedisys Inc (AMED)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 2,138,710 2,139,110 2,117,370 2,089,870 2,060,170 2,027,420 1,982,400 1,946,960 1,976,240 1,982,130 2,000,990 1,908,390 1,856,970 1,937,640 1,599,560 1,573,210 1,567,200 1,602,720 1,645,490 1,440,080
Total stockholders’ equity US$ in thousands 1,134,540 1,147,760 1,125,200 1,088,180 1,066,510 1,039,910 1,006,780 1,079,120 1,051,570 1,015,740 985,646 966,758 931,351 905,264 874,272 788,153 809,224 756,205 720,851 679,197
Financial leverage ratio 1.89 1.86 1.88 1.92 1.93 1.95 1.97 1.80 1.88 1.95 2.03 1.97 1.99 2.14 1.83 2.00 1.94 2.12 2.28 2.12

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $2,138,710K ÷ $1,134,540K
= 1.89

The financial leverage ratio of Amedisys Inc has displayed some fluctuations over the years. From March 31, 2020, to December 31, 2024, the ratio varied between 1.80 and 2.28. The trend shows some volatility but generally indicates that the company has been managing its debt levels effectively to support its operations and growth. It peaked at 2.28 in June 2020, suggesting higher reliance on debt during that period. Subsequently, the ratio decreased and remained relatively stable between 1.80 and 2.14 until December 31, 2024. Overall, the company's financial leverage ratio indicates a conservative approach towards debt management, maintaining a balanced capital structure, and avoiding excessive financial risk.


Peer comparison

Dec 31, 2024